Fortress Biotech (FBIO) Misses Q3 EPS by 72c

Fortress Biotech (NASDAQ: FBIO) reported Q3 EPS of ($0.94), $0.72 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $34.75 million versus the consensus estimate of $14.28 million.

For earnings history and earnings-related data on Fortress Biotech (FBIO) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13